BioWorld - Tuesday, January 14, 2025

BioWorld Science

May 3, 2017

View Archived Issues

GlaxoSmithKline offers pipeline progress report for first quarter 2017

Read More

Rigel describes novel JAK inhibitors

Read More

Medeor obtains IND clearance and SPA agreement with the FDA for phase III trial of MDR-101

Read More

Tesaro submits IND for TSR-033

Read More

Sunesis to withdraw MAA for vosaroxin in AML

Read More

Concert Pharmaceuticals initiates phase II trial of CTP-543 in alopecia areata

Read More

Corvus expands CPI-444 collaboration with Genentech

Read More

FDA grants fast track designation to ALT-803 as treatment for non-muscle invasive bladder cancer

Read More

FDA approves Tymlos for postmenopausal women with osteoporosis at high risk for fracture

Read More

Sanofi presents first-in-human data for the humanized anti-CD52 antibody GLD-52

Read More

Pieris and AstraZeneca establish respiratory disease collaboration

Read More

ZED-1227 for celiac disease completes phase Ib study

Read More

Mutations in NFKBIA found to confer resistance to multiple sclerosis treatment with MIS-416

Read More

FDA accepts IND for phase II trial of GKT-831 in primary biliary cholangitis

Read More

Agency for Science, Technology and Research (A*STAR) patents SMYD3 inhibitors

Read More

NIAID grant supports Lyndra's development of ultra-long acting HIV therapy

Read More

Selecta licenses LMB-100 from National Cancer Institute

Read More

FDA approves Ventana PD-L1 Assay as companion diagnostic for Imfinzi

Read More

Abivax reports effect of ABX-464 on HIV blood reservoir in phase IIa study

Read More

Gruenenthal identifies Cav2.2 channel blockers

Read More

French researchers present azaphenantrene analogues

Read More

FDA grants regenerative medicine advanced therapy designation to jCell

Read More

Sosei obtains equity stake and option to acquire MiNA Therapeutics

Read More